GlassScriptPhysician profile
Jatinder P Marwaha
NPI 1417910407
$3,891.94
in general payments reported to CMS, 2019-2025
33 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $429 · 2021: $543 · 2022: $411 · 2023: $772 · 2024: $756 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,272.07 | 2019-2025 | |
| Novo Nordisk INC | $547.04 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.14 | 2020-2025 | Jardiance |
| Glaxosmithkline, LLC. | $258.20 | 2021-2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $173.68 | 2019-2024 | Spravato |
| Allergan, INC. | $134.23 | 2019 | |
| Esperion Therapeutics, INC. | $103.11 | 2020-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $90.75 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.68 | 2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $73.05 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $60.60 | 2022-2023 | Prehevbrio |
| Eisai INC. | $57.27 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $56.21 | 2021 | |
| Merck Sharp & Dohme LLC | $55.05 | 2020-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Revance Therapeutics, INC. | $53.98 | 2024 | Daxxify |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $53.89 | 2022-2025 | Jardiance |
| Inspire Medical Systems, INC. | $38.68 | 2025 | Inspire |
| Gilead Sciences, INC. | $38.53 | 2020 | |
| Vanda Pharmaceuticals INC. | $35.02 | 2025 | Fanapt |
| Treace Medical Concepts, INC. | $33.89 | 2024 | |
| Exact Sciences Corporation | $29.20 | 2025 | The Cologuard Plus Collection Kit |
| Sunovion Pharmaceuticals INC. | $28.14 | 2019 | |
| Abbvie INC. | $27.94 | 2020 | |
| Orthofix Medical, INC. | $23.98 | 2024 | Physio-Stim |
| Dynavax Technologies Corporation | $22.89 | 2025 | Heplisav-B |
| Sanofi Pasteur INC. | $22.89 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $21.05 | 2023 | Rexulti |
| Seqirus USA INC | $19.85 | 2024 | Flucelvax, Fluad |
| Qiagen, LLC | $18.57 | 2019 | |
| Hartmann USA, INC. | $15.61 | 2022 | |
| Lupin INC. | $15.20 | 2019 | |
| Ceribell, INC. | $13.77 | 2020 | |
| Currax Pharmaceuticals LLC | $12.78 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jatinder Marwaha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.